NEW YORK (GenomeWeb) – Alere said today the US Food and Drug Administration has granted 510(k) clearance of its Alere i Influenza A & B 2 test for the faster detection of influenza A and B infection in children and adults.

Alere said that the test is a second-generation rapid molecular assay that delivers lab-accurate results and has the ability to report a positive result in as little as five minutes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.